Search research articles
Contact Us
Filters
Showing results (11-20 of 152) with videos related to
Page
of 16
Sort By:
Current Opinion in Nephrology and Hypertension
|
September 3, 2011
New insights into uremia-induced alterations in metabolic pathways
Eugene P Rhee, Ravi Thadhani
Methods in Molecular Biology (Clifton, N.J.)
|
January 19, 2020
Application of Metabolomics to Renal and Cardiometabolic Diseases
Casey M Rebholz, Eugene P Rhee
Clinical Chemistry
|
November 24, 2011
Metabolomics and cardiovascular biomarker discovery
Eugene P Rhee, Robert E Gerszten
Clinical Journal of the American Society of Nephrology : CJASN
|
October 23, 2019
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F Dubin, Eugene P Rhee
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 5, 2025
Interpreting Metabolomics and Proteomics in Kidney Disease: A Practical Guide
Insa M Schmidt, Eugene P Rhee
Med (New York, N.Y.)
|
May 11, 2024
siRNA takes a jab at hypertension
Kendra E Wulczyn, Eugene P Rhee
Clinical Journal of the American Society of Nephrology : CJASN
|
July 12, 2014
Metabolite markers of incident CKD risk
Eugene P Rhee, Harold I Feldman
Nephron
|
July 20, 2021
Fibroblast Growth Factor 23 Regulation and Acute Kidney Injury
Wen Zhou, Petra Simic, Eugene P Rhee
Journal of the American Society of Nephrology : JASN
|
June 26, 2025
Expanding Mechanistic Insights into Urinary Concentrating Ability
Richard S E Babicz, Eugene P Rhee
Current Opinion in Nephrology and Hypertension
|
April 26, 2021
Glycerol-3-phosphate and fibroblast growth factor 23 regulation
Petra Simic, Jodie L Babitt, Eugene P Rhee
Page
of 16
Search research articles
Search
Showing results (11-20 of 152) with videos related to
Sort By:
Page
of 16
Current Opinion in Nephrology and Hypertension
|
September 3, 2011
New insights into uremia-induced alterations in metabolic pathways
Eugene P Rhee, Ravi Thadhani
Methods in Molecular Biology (Clifton, N.J.)
|
January 19, 2020
Application of Metabolomics to Renal and Cardiometabolic Diseases
Casey M Rebholz, Eugene P Rhee
Clinical Chemistry
|
November 24, 2011
Metabolomics and cardiovascular biomarker discovery
Eugene P Rhee, Robert E Gerszten
Clinical Journal of the American Society of Nephrology : CJASN
|
October 23, 2019
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F Dubin, Eugene P Rhee
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 5, 2025
Interpreting Metabolomics and Proteomics in Kidney Disease: A Practical Guide
Insa M Schmidt, Eugene P Rhee
Med (New York, N.Y.)
|
May 11, 2024
siRNA takes a jab at hypertension
Kendra E Wulczyn, Eugene P Rhee
Clinical Journal of the American Society of Nephrology : CJASN
|
July 12, 2014
Metabolite markers of incident CKD risk
Eugene P Rhee, Harold I Feldman
Nephron
|
July 20, 2021
Fibroblast Growth Factor 23 Regulation and Acute Kidney Injury
Wen Zhou, Petra Simic, Eugene P Rhee
Journal of the American Society of Nephrology : JASN
|
June 26, 2025
Expanding Mechanistic Insights into Urinary Concentrating Ability
Richard S E Babicz, Eugene P Rhee
Current Opinion in Nephrology and Hypertension
|
April 26, 2021
Glycerol-3-phosphate and fibroblast growth factor 23 regulation
Petra Simic, Jodie L Babitt, Eugene P Rhee
Page
of 16